187 related articles for article (PubMed ID: 10908504)
1. Ropinirole versus bromocriptine for levodopa-induced complications in Parkinson's disease.
Clarke CE; Deane KH
Cochrane Database Syst Rev; 2000; 2001(3):CD001517. PubMed ID: 10908504
[TBL] [Abstract][Full Text] [Related]
2. Ropinirole versus bromocriptine for levodopa-induced complications in Parkinson's disease.
Clarke CE; Deane KH
Cochrane Database Syst Rev; 2001; (1):CD001517. PubMed ID: 11279719
[TBL] [Abstract][Full Text] [Related]
3. Ropinirole for levodopa-induced complications in Parkinson's disease.
Clarke CE; Deane KH
Cochrane Database Syst Rev; 2000; (3):CD001516. PubMed ID: 10908503
[TBL] [Abstract][Full Text] [Related]
4. Ropinirole for levodopa-induced complications in Parkinson's disease.
Clarke CE; Deane KH
Cochrane Database Syst Rev; 2001; (1):CD001516. PubMed ID: 11279718
[TBL] [Abstract][Full Text] [Related]
5. Cabergoline versus bromocriptine for levodopa-induced complications in Parkinson's disease.
Clarke CE; Deane KD
Cochrane Database Syst Rev; 2001; 2001(1):CD001519. PubMed ID: 11279721
[TBL] [Abstract][Full Text] [Related]
6. Pramipexole versus bromocriptine for levodopa-induced complications in Parkinson's disease.
Clarke C E; Speller J M; Clarke J A
Cochrane Database Syst Rev; 2000; 2000(3):CD002259. PubMed ID: 10908539
[TBL] [Abstract][Full Text] [Related]
7. Catechol-O-methyltransferase inhibitors versus active comparators for levodopa-induced complications in Parkinson's disease.
Deane KH; Spieker S; Clarke CE
Cochrane Database Syst Rev; 2004 Oct; 2004(4):CD004553. PubMed ID: 15495118
[TBL] [Abstract][Full Text] [Related]
8. Cabergoline for levodopa-induced complications in Parkinson's disease.
Clarke CE; Deane KH
Cochrane Database Syst Rev; 2001; 2001(1):CD001518. PubMed ID: 11279720
[TBL] [Abstract][Full Text] [Related]
9. Pergolide versus bromocriptine for levodopa-induced motor complications in Parkinson's disease.
Clarke C E; Speller J M
Cochrane Database Syst Rev; 2000; (2):CD000236. PubMed ID: 10796705
[TBL] [Abstract][Full Text] [Related]
10. Pramipexole for levodopa-induced complications in Parkinson's disease.
Clarke C E; Speller J M; Clarke J A
Cochrane Database Syst Rev; 2000; 2000(3):CD002261. PubMed ID: 10908540
[TBL] [Abstract][Full Text] [Related]
11. Lisuride versus bromocriptine for levodopa-induced complications in Parkinson's disease.
Clarke CE; Speller JM
Cochrane Database Syst Rev; 2000; 1999(2):CD001514. PubMed ID: 10796800
[TBL] [Abstract][Full Text] [Related]
12. Tolerability and safety of ropinirole versus other dopamine agonists and levodopa in the treatment of Parkinson's disease: meta-analysis of randomized controlled trials.
Kulisevsky J; Pagonabarraga J
Drug Saf; 2010 Feb; 33(2):147-61. PubMed ID: 20082541
[TBL] [Abstract][Full Text] [Related]
13. Pergolide for levodopa-induced complications in Parkinson's disease.
Clarke C E; Speller J M
Cochrane Database Syst Rev; 2000; (2):CD000235. PubMed ID: 10796704
[TBL] [Abstract][Full Text] [Related]
14. Bromocriptine versus levodopa in early Parkinson's disease.
Ramaker C; van Hilten JJ
Cochrane Database Syst Rev; 2000; (3):CD002258. PubMed ID: 10908538
[TBL] [Abstract][Full Text] [Related]
15. Ropinirole as an adjunct to levodopa in the treatment of Parkinson's disease: a 16-week bromocriptine controlled study.
Im JH; Ha JH; Cho IS; Lee MC
J Neurol; 2003 Jan; 250(1):90-6. PubMed ID: 12527999
[TBL] [Abstract][Full Text] [Related]
16. Catechol-O-methyltransferase inhibitors for levodopa-induced complications in Parkinson's disease.
Deane KH; Spieker S; Clarke CE
Cochrane Database Syst Rev; 2004 Oct; 2004(4):CD004554. PubMed ID: 15495119
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the efficacy and safety of adjuvant treatment to levodopa therapy in Parkinson s disease patients with motor complications.
Stowe R; Ives N; Clarke CE; Deane K; ; Wheatley K; Gray R; Handley K; Furmston A
Cochrane Database Syst Rev; 2010 Jul; (7):CD007166. PubMed ID: 20614454
[TBL] [Abstract][Full Text] [Related]
18. A six-month multicentre, double-blind, bromocriptine-controlled study of the safety and efficacy of ropinirole in the treatment of patients with Parkinson's disease not optimally controlled by L-dopa.
Brunt ER; Brooks DJ; Korczyn AD; Montastruc JL; Stocchi F;
J Neural Transm (Vienna); 2002 Apr; 109(4):489-502. PubMed ID: 11956968
[TBL] [Abstract][Full Text] [Related]
19. Lisuride for levodopa-induced complications in Parkinson's disease.
Clarke CE; Speller JM
Cochrane Database Syst Rev; 2000; 1999(2):CD001515. PubMed ID: 10796801
[TBL] [Abstract][Full Text] [Related]
20. Bromocriptine versus levodopa in early Parkinson's disease.
van Hilten JJ; Ramaker CC; Stowe R; Ives NJ
Cochrane Database Syst Rev; 2007 Oct; 2007(4):CD002258. PubMed ID: 17943771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
